"We are proud and excited about this project," adds Prof. Jan Lagendijk, Department of Radiotherapy, University Medical Center Utrecht. "Elekta, Philips and my department have strived for over a decade to make this possible. Through real-time imaging of both tumors and organs at risk, an integrated MRI-guided radiation therapy system would enable us to see more precisely than ever what we treat, and irradiate just the tumor as it moves in the body during treatment. This could potentially bring significant benefits to patients and overall healthcare economics."
Radiotherapy is one of the primary modalities used to treat cancer, either as a stand alone treatment or used with other modalities such as chemotherapy. The technique involves identifying cancerous tissue and irradiating it with high energy radiation beams in a way that maximizes sparing of healthy tissue near the tumor. Radiation therapy delivered by linear accelerators and medical imaging already play an essential role in treatment planning, delivery and after care and is a proven cost-effective and safe method for treating patients with cancer.
Ad Statistics
Times Displayed: 22141
Times Visited: 439 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
*The integrated MRI-guided radiation therapy system is in development and not available for sale.
For further information, please contact:
Johan Andersson Melbi, Director, Investor Relations, Elekta ABTel: +46 702 100 451, E-mail: johan.anderssonmelbi@elekta.com Time zone: CET: Central European Time
Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta Tel: +1 770-670-2447, E-mail: michelle.joiner@elekta.com Time zone: ET: Eastern Time
Steve Klink, Philips Corporate CommunicationsTel.: +31 20 5977415, E-mail: steve.klink@philips.com
About ElektaElekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com .
